tiprankstipranks
Takeda Pharmaceutical Co Ltd (TKPHF)
OTHER OTC:TKPHF
US Market
TKPHF
Takeda Pharmaceutical Co
RESEARCH TOOLSreports
Want to see TKPHF full AI Analyst Report?

Takeda Pharmaceutical Co (TKPHF) Income Statement

35 Followers

Takeda Pharmaceutical Co Income Statement

Last quarter (Q4 2025), Takeda Pharmaceutical Co's total revenue was ¥1.09T, an increase of 3.91% from the same quarter last year. In Q4, Takeda Pharmaceutical Co's net income was ¥-24.32B. See Takeda Pharmaceutical Co’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Mar 26Mar 25Mar 24Mar 23Mar 22
Total Revenue
¥ 4.51T¥ 4.58T¥ 4.26T¥ 4.03T¥ 3.57T
Gross Profit
¥ 2.30T¥ 2.46T¥ 2.32T¥ 2.30T¥ 2.04T
Operating Expenses
¥ 1.76T¥ 1.83T¥ 1.79T¥ 1.64T¥ 1.43T
Depreciation and Amortization
¥ 721.13B¥ 761.40B¥ 728.00B¥ 664.40B¥ 583.15B
EBITDA
¥ 1.26T¥ 1.13T¥ 927.95B¥ 1.18T¥ 1.04T
Operating Income
¥ 540.45B¥ 627.54B¥ 531.42B¥ 658.29B¥ 610.50B
Other Income/Expenses
¥ -280.26B¥ -452.46B¥ -478.63B¥ -283.20B¥ -307.93B
Pretax Income
¥ 260.19B¥ 175.08B¥ 52.79B¥ 375.09B¥ 302.57B
Net Income
¥ 191.76B¥ 107.93B¥ 144.07B¥ 317.02B¥ 230.06B
Per Share Metrics
Basic EPS
¥ 121.75¥ 68.36¥ 92.09¥ 204.29¥ 147.14
Diluted EPS
¥ 119.64¥ 67.23¥ 91.16¥ 201.94¥ 145.87
Weighted Average Shares Outstanding
 1.58B 1.58B 1.56B 1.55B 1.56B
Weighted Average Shares Outstanding (Diluted)
 1.60B 1.61B 1.58B 1.57B 1.58B
Currency in JPY

Takeda Pharmaceutical Co Earnings and Revenue History